By Joey Wong, Investor Research Analyst, LSN
Digital Redefining Early Stage Investment (RESI) Conference, June 8-10, takes place in just a few weeks! The Life Science Nation (LSN) investor research team has been busy organizing six exciting panels focusing on different investor groups, from big pharma, corporate venture capital, to family offices and angel investors, etc. During these panels, active life science investors will share their insight and provide tactical advice on outreach, positioning, and building the right relationships to move products forward. The goal is to facilitate constructive conversations between investors and fundraising CEOs, and provide insights on how companies can raise capital and acquire partnerships effectively.
Another exciting part of the upcoming conference is the Innovator’s Pitch Challenge, where investors and industry experts are invited to participate in the live Q&A sessions to give feedback and ask questions to the pitching companies.
If you are interested in meeting these investor panelists and pitch judges, register here for Digital RESI June! Partnering is open, but there is still time to sign up!
For those who have already registered, we highly recommend you to join the panels that are relevant to your company; you can RSVP for any panels in the partnering system to block off your meeting schedule.
Here are some of the investors who will be joining our panels and pitch sessions at Digital RESI June:
 |
 |
 |
 |
| Hamzeh Abdul-Hadi Principal Hikma Ventures |
Brent Ahrens General Partner Canaan Partners |
Faz Bashi Member of BOD Life Science Angels |
Attila Bérces Advisor FastVentures |
 |
 |
 |
 |
| Brian Bronk Head of External Innovation, Rare Diseases Sanofi |
Hannah Chang Managing Director Wu Capital |
Elizabeth Cho-Fertikh Co-Founder & Managing Director Meda Angels |
Chris Church Associate Director, Search & Evaluation, CVRM AstraZeneca |
 |
 |
 |
 |
| Juan Cueva Senior Associate Action Potential Venture Capital |
Geoff Dacosta Director, Business Development and Licensing Medtronic |
Ben Evans Managing Director InHealth Ventures |
Naomi Fried Managing Director & Co-Founder Ambit Health Ventures |
 |
 |
 |
 |
| Robert Garber Partner 7wire Ventures |
Miles Gerson Partner Takeda Ventures |
Sam Goldberger Co-Founder & Managing Partner Ambit Health Ventures |
Sherry Grisewood Senior Investment Officer FoxHill Asset Management |
 |
 |
 |
 |
| Bryan Grulke Partner Volcano Capital |
Eric Heinz Director, Business Development (M&A) Smith & Nephew |
Merom Klein Entrepreneur Mentor Keiretsu Forum |
Marc Martin-Casas Seed Investments & Development Illumina Accelerator |
 |
 |
 |
 |
| Andy Merken Partner, Corporate and Securities Co-Chair, Life Sciences Burns & Levinson |
Brian Meshkin Managing Partner, Profound Ventures Partner, Cancer Fund Profound Ventures |
Petra Meyer Managing Director – HealthCare Sector Group Lead Golden Seeds |
Junaid Mian Managing Partner & Longevity Lead SP8CEVC |
 |
 |
 |
 |
| Nicholas Mourlas Senior Director, New Ventures Johnson & Johnson Innovation |
Ashley Ng Director McKesson Ventures |
John Parker Founder & Managing Director Springhood Ventures |
Richard Proscia Senior Associate Providence Ventures |
 |
 |
 |
 |
| Meghana Rao Senior Manager, New Venture Transactions Johnson & Johnson Innovation |
Nadav Shimoni Head, Digital Health Arkin Holdings Ltd |
Yaniv Sneor Founding Member Mid Atlantic Bio Angels |
Jill Sorensen Chief Operating Officer Medical Technology Enterprise Consortium (MTEC) |
 |
 |
 |
 |
| Eran Steinberg
Imaging Arts |
Ben Sun Investor/member Sand Hill Angels |
Anna Turetsky Principal, Venture Investments The Mark Foundation for Cancer Research (MFCR) |
Thomas Vogelsong Investor/Life Science Advisor KYTO Technology and Life Science |
 |
 |
 |
|
| Scott Weiner Partner Amzak Health |
Tim Xiao Principal Delos Capital |
John Yianni Managing Partner Earlybird |
Next Phase Newsletter 
Leave a Reply